The option-trade picking algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center have selected a covered-call trade on Edwards Lifesciences Corp (http://www.marketintelligencecenter.com/symbol/EW"EW) that includes 6.25% ... Individual.com, 1 day ago
Potential Edwards Lifesciences (EW) Trade Has 4.37% Downside Protection - Individual.com, 4 days ago
Edwards Lifesciences (EW) Showing Bullish Technicals With Support At $124.85 - Individual.com, 3 weeks ago
3 images for "edward lifesciences"
SmarTrend identified an Uptrend for Edwards Lifesciences (NYSE:EW) on October 23rd, 2014 at $106.16. In approximately 3 months, Edwards Lifesciences has returned 20.81% as of today's recent priceIndividual.com, 6 days ago Uptrend Call Working As Edwards Lifesciences Stock Rises 19.6% (EW) Individual.com, 3 weeks ago Edwards Lifesciences Shares Up 22.9% Since SmarTrend's Buy Recommendation (EW) Individual.com, 4 weeks ago Edwards Lifesciences Up 24.8% Since SmarTrend Uptrend Call (EW) Individual.com, 1 month ago
By a News Reporter-Staff News Editor at Cardiovascular Week -- A patent by the inventors Brunnett, William C. ( Mission Viejo, CA ); Curtis, Alison S. ( Irvine, CA ), filed on November 28, 2011 , was published online on January 13, 2015 , according ...4 Traders, 4 days ago Edwards Lifesciences reports February 3 Seeking Alpha, 1 week ago
(Financial News Network On) One week ago Edwards Lifesciences (NYSE:EW) was downgraded from Outperform to Market Perform at Northland. Edwards Lifesciences shares are selling at $135.29, 5.9% above the $127.78 price point of one week ago.Individual.com, 2 weeks ago
Edwards Lifesciences (NYSE:EW), a company whose shares are moving quickly, is trading 2.1% higher to $129.72. The Dow is up 1.0% to 17,543 and the S&P is currently up 1.0%Individual.com, 2 weeks ago Stock Investors Bid Up Shares of Edwards Lifesciences, Up 3.1% Individual.com, 1 month ago
Edwards Lifesciences has the Lowest EBITDA Growth in the Health Care Equipment Industry (EW, SNN, THOR, EXAC, SRDX)
Written on Sun, 01/11/2015 - 11:23am By David Diaz Below are the three companies in the Health Care Equipment industry with the lowest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow ...Comtex SmarTrend, 2 weeks ago Shares of Edwards Lifesciences Rank the Lowest in Terms of EBITDA Growth in the Health Care Equipment Industry (EW, SNN, THOR, EXAC, MDT) Individual.com, 1 month ago Edwards Lifesciences is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (EW, DXCM, VAR, RMD, BDX) Comtex SmarTrend, 1 month ago Idexx Laboratories is Among the Companies in the Health Care Equipment Industry With the Highest Return on Equity (IDXX, BCR, EW, CYBX, VAR) Comtex SmarTrend, 1 week ago
In this article, let's take a look at Edwards Lifesciences Corp. (EW), a $13.62 billion market cap company that makes and markets a comprehensive line of products and services to treat late-stage cardiovascular disease. Key to growth The company ...Yahoo! Finance, 1 month ago
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Edwards Lifesciences Corp. ( EW ), a firm in the medical instruments industry, which could be a great candidate for another beat. This company has ...Yahoo! Finance, 1 month ago
Edwards Lifesciences : CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
By a News Reporter-Staff News Editor at Investment Weekly News -- CardioKinetix, Inc. , a medical device company pioneering a catheter-based treatment for heart failure, announced that it has completed a $50 million financing led by Edwards ...4 Traders, 1 month ago CardioKinetix signs option-to-buy agreement with Edwards Lifesciences; raises $50M | Medtech funding for the week of December 8, 2014 MassDevice, 1 month ago CardioKinetix Finalizes $50M Financing with Edwards Lifesciences Individual.com, 1 month ago CardioKinetix Gets $50 Million Infusion, Inks Accord with Edwards Lifesciences FDA News, 1 month ago
By Jof Enriquez Edwards Lifesciences recently announced a $50 million investment in CardioKinetix, a privately-held company developing a novel intracatheter implant for heart failure patients. The financing deal will help CardioKinetix ...Medical Design Online, 1 month ago Edwards Lifesciences Invests $50 Million in New Heart Failure Technology Investing.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!